Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Infections × gilteritinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 2 Infections 1

Interventions

tocilizumab 1 golimumab 1 gilteritinib 1 Tumor Necrosis Factor Inhibitors 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Saline Solution 1 Probiotics 1 Polymerase Chain Reaction 1 Observation 1 Levofloxacin 1 Infliximab 1 Immunoenzyme Techniques 1 Etanercept 1 Docosahexaenoic Acids 1 Clarithromycin 1 Cefoxitin 1 Cefepime 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Antibiotic Prophylaxis 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05791890 2023-03-30

GilteRInf

University of Rome Tor Vergata

Other hematologic neoplasm

Infections, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡